Lipids & Cholesterol Disorders News | LDL, HDL Treatment Studies

Lipids and Cholesterol

LIPIDS AND CHOLESTEROL

Latest News

FDA Panel Votes on Vascepa for Cardiovascular Risk Reduction

The FDA’s Endocrinologic and Metabolic Drugs Advisory Committee voted in favor (16-0) to recommend the approval of Vascepa (icosapent ethyl capsules; Amarin) to reduce residual cardiovascular (CV) risk in patients with statin-managed low density lipoprotein (LDL) cholesterol, but persistent elevated triglycerides.